Tabiki zor durumda ama böyle bir ilaç için millet böbreğini satar desem yeri var. Madem sağlık bakanlığı ile çalışıyorlar ve o araştırmalar Türkiye'de yapıldı ozaman orada çıkarmak çok mantıklı olur, tabiki Amerika'daki fiyatı isteyebilir mi yoksa öyle düşünüyorlar mıdır bilemem.
Anladığım kadar losyon olarak çıkacak, çoğu tedaviler öyle olacak gibi. Besin takviyesi gerek olduğunu düşünmüyorum, şu ana kadar sırf 3 aylık bilgiler var, önemli olan gelecek veriler ve bir sene sonraki sonuçlar.
i am a medical student at this university
Lol, thats weird
Super, do you have any additional information about the studies?i am a medical student at this university
thanks for the translation
I am currently in another city due to covid. I'm sure there are some people in the forum who are in the same city right now. the professor works in a private practice. If I were there, I would go and make an appointment, maybe someone would do that for us. Also, nobody knows anything in Turkish forums. Either the drug is really ineffective or no one can say anything because of very strict rules.
I got it buddy, thanks
Maybe, but he does make some good points, and it's rather difficult to prove a sophisticated fraud like that. You just have to wonder why they do certain things like performing their trials in house, or raising funds solely from individuals rather than investment banks that would demand more rigid oversight. I don't think they are fabricating data outright, but would you be surprised if they are manipulating the trial design and stats to make it appear better than it is? If their former employee is right this would be a soft fraud, in which they have real drugs and conduct real trials, it's just that the drugs are ineffective and they know it. You can dupe more investors by running trials with legitimate but ineffective drugs than by not running any trials. Time will tell, but don't be surprised if this company just keeps running trials until the money stops coming in, but never releases a product outside of Turkey.
If this same employee had said something good about this drug you would have not believed him, saying his words without evidence mean nothing.
That's where you're wrong, I'm simply being objective. I'm open to anything positive about the company too. I just see a lot to be skeptical of here. I'm much more optimistic about Bayer, Follica, Surrozen, Tissuse, and Stemson.
Faz 3 çalışmasını bitirmiş bir ilaç olduğu için ilgilenmemiz normaldir
They feel exposed
We come from asia
I'm not saying those guys are not having sides, but I don't think heart fluttering alone would have derailed this trail, so it's a pretty inconclusive call to say that the drug was dropped for safety concerns. Minoxidil gives me heart palpitations and fluttering from time to time, and is a known minor side effect, yet the drug is sold over the counter.Lol, what am I reading...
Yes one of samumed's osteoarthritis phase II trials "failed" but that doesn't mean Samumed is dropping it, there are phase III trials underway.
And RU not going to market could be because of many reasons. Patent rights for example:
ru-58841.com - ru 58841 Resources and Information.
ru-58841.com is your first and best source for all of the information you’re looking for. From general topics to more of what you would expect to find here, ru-58841.com has it all. We hope you find what you are searching for!www.ru-58841.com
the patent for RU58841 was already quite old when the second clinical trial was finished. If a company would go forward to bring RU58841 to the market then it would only have a short amount of time to generate revenue before other companies could compete and create generic versions.
Also the company behind RU valuating the hairloss market at only 200 million was 20 years ago, I don't need to tell anyone here how important appearance for a man is these days. The market is MUCH bigger than that these days.
But I believe they dropped RU because of safety risks. Also many guys on this forum experiencing sides from RU, especially heart problems. (recent thread: https://www.hairlosstalk.com/intera...tions-from-using-ru58841.130225/#post-1923685 )
RU trialling was dropped due to safety concerns over systemic absorption - here's the snippet:
"Furthermore, the absence of a full toxicological report on RU-58841 in any species and the lack of human clinical data has led us to the assumption that product development has been abandoned."
Comparing SM04554 to RU's situation back in the day doesn't make any sense, too many different variables.
Also comparing Samumed to Theranos? Really now? Lol!
Anyway, being sceptical is good. We've been burned enough. But Samumed is no fraud, there is absolutely zero evidence that they are. It's all wild speculation based on nothing.
Ya everyone is disregarding what you are saying because you have literally no basis for your claims. What exactly about the 90 day trial mostly geared towards safety didn't do it for you? And further, is a 24 month trial not a very effective medium for pushing the drug to market? I have much more doubts about the garbage that Casseopia is trying to pull with a sham of a 6 month phase 3 trial the most comprehensive phase 3 trial completed in this space since Propecia.